I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Event-Free Survival in Patients with Early HER2-Positive Br..:
Sandra M. Swain
;
Harrison Macharia
;
Javier Cortes
...
https://www.mdpi.com/2072-6694/14/20/5051. , 2022
Link:
https://doi.org/10.3390/cancers14205051
RT Journal T1
Event-Free Survival in Patients with Early HER2-Positive Breast Cancer with a Pathological Complete Response after HER2-Targeted Therapy: A Pooled Analysis
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:403b60149a1e4c7bb2f94b786a5ef237&Exemplar=1&LAN=DE A1 Sandra M. Swain A1 Harrison Macharia A1 Javier Cortes A1 Chau Dang A1 Luca Gianni A1 Sara A. Hurvitz A1 Christian Jackisch A1 Andreas Schneeweiss A1 Dennis Slamon A1 Pinuccia Valagussa A1 Yolande du Toit A1 Dominik Heinzmann A1 Adam Knott A1 Chunyan Song A1 Patricia Cortazar PB MDPI AG YR 2022 K1 dual HER2 targeting K1 early breast cancer K1 event-free survival K1 HER2 K1 pathologic complete response K1 pertuzumab K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF https://www.mdpi.com/2072-6694/14/20/5051 LK http://dx.doi.org/https://doi.org/10.3390/cancers14205051 DO https://doi.org/10.3390/cancers14205051 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)